Hunan Nucien Pharmaceutical Co Ltd
SSE:688189
Wall Street
Price Targets
Price Targets Summary
Hunan Nucien Pharmaceutical Co Ltd
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Hunan Nucien Pharmaceutical Co Ltd's stock price target?
Not Available
Hunan Nucien Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Hunan Nucien Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
38%
For the last 6 years the compound annual growth rate for Hunan Nucien Pharmaceutical Co Ltd's revenue is -15%. The projected CAGR for the next 3 years is 38%.